Company Search:
Advanced Search
Sponsored Links
Pyridam Farma Tbk PT Company Snapshot
Pyridam Farma Tbk PT operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Pyridam Farma Tbk PT with three other pharmaceutical manufacturers in Asia: iNtRON Biotechnology Inc of South Korea (2018 sales of 20.58 billion Korean Won [US$17.78 million] of which 55% was Technology Export), Jagsonpal Pharmaceuticals Limited of India (1.27 billion Indian Rupees [US$17.75 million] ), and Chem Tech Research Inc which is based in South Korea (20.54 billion Korean Won [US$17.75 million] of which 26% was OTC entrusted).

Sales Analysis. Pyridam Farma Tbk PT reported sales of 250.45 billion Indonesian Rupiahs (US$17.88 million) for the year ending December of 2018. This represents an increase of 12.3% versus 2017, when the company's sales were 223.00 billion Indonesian Rupiahs.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Pyridam Farma Tbk PT
  Stock Performance Chart for Pyridam Farma Tbk PT
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 202.00
(Figures in Indonesian Rupiahs)
1 Week 3.6%   13 Weeks 26.3%  
4 Weeks 13.5%   52 Weeks 1.0%  
Pyridam Farma Tbk PT Key Data:
  Ticker: PYFA Country: Indonesia
  Exchanges: OTH JAK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 250,445,853,364
(Year Ending Jan 2019).
Employees: 700
  Currency: Indonesian Rupiahs Market Cap: 108,086,160,000
  Fiscal Yr Ends: December Shares Outstanding: 535,080,000
  Share Type: Ordinary Closely Held Shares: 448,409,285
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.